Menu
GWAS Study

A genome-wide identified risk variant for PTSD is a methylation quantitative trait locus and confers decreased cortical activation to fearful faces.

Almli LM, Stevens JS, Smith AK et al.

25988933 PubMed ID
GWAS Study Type
3015 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AL
Almli LM
SJ
Stevens JS
SA
Smith AK
KV
Kilaru V
MQ
Meng Q
FJ
Flory J
AD
Abu-Amara D
HR
Hammamieh R
YR
Yang R
MK
Mercer KB
BE
Binder EB
BB
Bradley B
HS
Hamilton S
JM
Jett M
YR
Yehuda R
MC
Marmar CR
RK
Ressler KJ
Chapter II

Abstract

Summary of the research findings

Genetic factors appear to be highly relevant to predicting differential risk for the development of post-traumatic stress disorder (PTSD). In a discovery sample, we conducted a genome-wide association study (GWAS) for PTSD using a small military cohort (Systems Biology PTSD Biomarkers Consortium; SBPBC, N = 147) that was designed as a case-controlled sample of highly exposed, recently returning veterans with and without combat-related PTSD. A genome-wide significant single nucleotide polymorphism (SNP), rs717947, at chromosome 4p15 (N = 147, β = 31.34, P = 1.28 × 10(-8) ) was found to associate with the gold-standard diagnostic measure for PTSD (the Clinician Administered PTSD Scale). We conducted replication and follow-up studies in an external sample, a larger urban community cohort (Grady Trauma Project, GTP, N = 2006), to determine the robustness and putative functionality of this risk variant. In the GTP replication sample, SNP rs717947 associated with PTSD diagnosis in females (N = 2006, P = 0.005), but not males. SNP rs717947 was also found to be a methylation quantitative trait locus (meQTL) in the GTP replication sample (N = 157, P = 0.002). Further, the risk allele of rs717947 was associated with decreased medial and dorsolateral cortical activation to fearful faces (N = 53, P < 0.05) in the GTP replication sample. These data identify a genome-wide significant polymorphism conferring risk for PTSD, which was associated with differential epigenetic regulation and with differential cortical responses to fear in a replication sample. These results may provide new insight into understanding genetic and epigenetic regulation of PTSD and intermediate phenotypes that contribute to this disorder.

32 Hispanic ancestry cases, 16 Black cases, 14 European ancestry cases, 1 other ancestry case, 25 Hispanic ancestry controls, 6 Asian ancestry controls, 19 Black controls, 31 European ancestry controls, 3 other ancestry controls

Chapter III

Study Statistics

Key metrics and study information

3015
Total Participants
GWAS
Study Type
Yes
Replicated
2,868 African American ancestry individuals
Replication Participants
African American or Afro-Caribbean, African unspecified, Other, Asian unspecified, European, Hispanic or Latin American
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.